Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.5040
-0.0150 ( -2.89% ) N/A
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.5040
Previous close
$0.5190
Volume
N/A
Market cap
$82.37M
Day range
$0.5190 - $0.5190
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Feb 22, 2024 |
| 4 | Insider transactions | 1 | Feb 20, 2024 |
| 3/a | Insider transactions | 1 | Feb 16, 2024 |
| 8-k | 8K-related | 14 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 15, 2024 |
| 8-k | 8K-related | 21 | Feb 14, 2024 |
| 10-q | Quarterly Reports | 94 | Feb 14, 2024 |